Navigation Links
H1N1 Flu Vaccine Very Effective: Study
Date:2/3/2011

THURSDAY, Feb. 3 (HealthDay News) -- A single dose of the H1N1 swine flu vaccine was 93 percent effective during the 2009 pandemic, a new study found.

In order to assess the effectiveness of the vaccine -- known as the AS03-adjuvanted pandemic H1N1 vaccine -- Canadian researchers looked at 552 patients with flu-like illness who visited clinics in four provinces between Nov. 8 and Dec. 5, 2009.

Pandemic H1N1 was detected in 209 (38 percent) of the patients. Two (1 percent) of the patients with H1N1 flu had received a single dose of the H1N1 vaccine at least two weeks before they became ill, compared with 58 (17 percent) of patients who didn't have H1N1 infection.

The findings show that the vaccine was 93 percent effective, said the researchers, who were led by Danuta Skowronski at the British Columbia Centre for Disease Control in Vancouver.

The findings apply not only to Canada but other countries where vaccines were used, and may help guide the further development of influenza vaccine options, the researchers said.

More than 80 percent of the people in the study were younger than 50, so evidence of the effectiveness of the vaccine in the elderly is still needed, they noted.

The study appeared in the Feb. 3 online edition of BMJ.

More information

The U.S. Centers for Disease Control and Prevention has more about H1N1 flu.

-- Robert Preidt

SOURCE: BMJ, news release, Feb. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Last Years H1N1 Flu Vaccine Was Safe, Study Finds
2. Gardasil Vaccine Guards Against HPV in Boys
3. New study identifies potential vaccine to prevent gastritis, ulcer disease, gastric cancer
4. Southampton scientists begin patient trials of new leukemia cancer vaccine
5. Fear of Vaccines Has a Long, Persistent History
6. NIH, Gates Foundation and Colorado State team up to find new approach to a TB vaccine
7. New discovery could lead to vaccines for plague and bacterial pneumonias
8. Nearly Half of Americans Still Suspect Vaccine-Autism Link
9. Researchers unzip MRSA and discover route for vaccine
10. Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
11. Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... Illinois (PRWEB) , ... April ... ... the leading provider of enterprise Data Center Infrastructure Management solutions, announces today ... focuses on feature enhancements in the area of capacity management and optimization, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and ... Surgery Collaborative Residency Network. The platform is scheduled to launch in July 2016 ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: